NEWS

New partnership aims to create a surgical intelligence ecosystem that transforms how shoulder replacement is delivered, measured, and continuously improved across the full episode of care NAPLES, Fla., Sept. 23, 2026 – Catalyst OrthoScience, Inc. ("Catalyst"), a private medical technology company elevating shoulder arthroplasty through surgeon-focused innovation, today announced it…

Agreement enables continued focus on differentiated innovation, growing adoption, and surgeon partnership NAPLES, Fla., Sept. 9, 2026 - Catalyst OrthoScience Inc. (“Catalyst”), a private medical device  technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced that it has entered into a settlement agreement with Shoulder Innovations, Inc. (“Shoulder…

Medtech leader with deep orthopedic extremities experience enhances board depth as shoulder-focused company advances growth and strategic objectives NAPLES, Fla., May 13, 2026 - Catalyst OrthoScience Inc. (“Catalyst”), a private medical device technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced the appointment of Gordon Van Ummersen to…

Celebrating a decade of innovation, the latest technology expands Catalyst’s efficiency-driven approach to shoulder arthroplasty – making it the first and only company in the industry to offer a single-tray portfolio for anatomic, reverse, and fracture procedures NAPLES, Fla., April 16, 2026 - Catalyst OrthoScience Inc. (“Catalyst”), a private medical…

New patient-specific solution expands Catalyst’s portfolio, enabling precise translation of 3D surgical plans into the operating room to reduce steps and increase accuracy   NAPLES, Fla., Feb. 25, 2026 - Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced U.S. Food…

New indications expand applications for Catalyst Fracture System to anatomic shoulder restorations NAPLES, Fla., Dec. 3, 2025 – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced that its Catalyst Fracture Shoulder System has received FDA 510(k) clearance for additional indications that now include…

RC Capital, Mutual Capital Partners and Western Alliance Bank, reinforce long-term confidence in Catalyst’s vision and leadership; Dr. Theodore Blaine joins Catalyst board of directors  NAPLES, Fla., Oct. 22, 2025 – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced the…

The new system designed to improve reverse shoulder arthroplasty for proximal humeral fractures includes patented technology that helps reduce surgical complexity and drive clinical confidence NAPLES, Fla., August 12, 2025 – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the…

Mid-term results for Catalyst CSR™ shoulder system include outcomes for 200+ shoulders and show exceptionally high patient satisfaction scores in a wide age range of patients NAPLES, Fla., June 4, 2025 – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in…